Partners Group-led investor group to sell PCI Pharma Services
Partners Group, the global private markets investment manager, has agreed the sale of a majority equity stake in PCI Pharma Services on behalf of its clients and alongside its investment partners Thomas H. Lee Partners and Frazier Healthcare Partners. Following the sale to private equity firm Kohlberg & Company and Abu Dhabi-based sovereign investor Mubadala Investment Company, Partners Group will retain a meaningful minority equity stake in the Company. The terms of the transaction are not disclosed.
PCI, which is headquartered in Philadelphia, PA, is a global provider of outsourced pharmaceutical supply chain solutions supporting biotechnology and pharmaceutical companies throughout the various stages of drug development and commercialization. Partners Group acquired a majority stake in PCI in June 2016, on behalf of its clients.
Legal aspects of the deal were handled by Andreas Knecht (Partner, COO and General Counsel, Member of the Executive Committee and Global Executive Board at Partners Group Holding), Shari Wolkon (Managing Director and General Counsel at Thomas H. Lee Partners) Daniel S. Gewanter (in house lawyer at Kohlberg & Company).
Paul Weiss Rifkind Wharton & Ga acted as advisor to Kohlberg & Company with Angelo Bonvino and Sarah Stasny. Goodwin Procter also served as legal counsel.
.
